vs
Side-by-side financial comparison of Cincinnati Financial (CINF) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $2.8B, roughly 1.9× Cincinnati Financial). Cincinnati Financial runs the higher net margin — 9.6% vs 7.9%, a 1.6% gap on every dollar of revenue. On growth, Fresenius Medical Care AG posted the faster year-over-year revenue change (-0.3% vs -1.7%).
Cincinnati Financial Corporation offers property and casualty insurance, its main business, through The Cincinnati Insurance Company, The Cincinnati Indemnity Company and The Cincinnati Casualty Company. The company has 1.01% of the domestic property and casualty insurance premiums, which ranks it as the 20th largest insurance company by market share in the U.S.
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
CINF vs FMS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.8B | $5.5B |
| Net Profit | $274.0M | $434.2M |
| Gross Margin | — | 27.4% |
| Operating Margin | — | 11.7% |
| Net Margin | 9.6% | 7.9% |
| Revenue YoY | -1.7% | -0.3% |
| Net Profit YoY | — | 240.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $2.8B | — | ||
| Q4 25 | $3.1B | $5.5B | ||
| Q3 25 | $3.7B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.5B | $5.5B | ||
| Q3 24 | $3.3B | — | ||
| Q2 24 | $2.5B | — |
| Q1 26 | $274.0M | — | ||
| Q4 25 | $676.0M | $434.2M | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $685.0M | — | ||
| Q1 25 | $-90.0M | — | ||
| Q4 24 | $405.0M | $127.6M | ||
| Q3 24 | $820.0M | — | ||
| Q2 24 | $312.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 25.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | 27.2% | 11.7% | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 26.3% | — | ||
| Q1 25 | -5.0% | — | ||
| Q4 24 | 18.9% | 5.1% | ||
| Q3 24 | 31.3% | — | ||
| Q2 24 | 15.2% | — |
| Q1 26 | 9.6% | — | ||
| Q4 25 | 21.9% | 7.9% | ||
| Q3 25 | 30.1% | — | ||
| Q2 25 | 21.1% | — | ||
| Q1 25 | -3.5% | — | ||
| Q4 24 | 16.0% | 2.3% | ||
| Q3 24 | 24.7% | — | ||
| Q2 24 | 12.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | $4.29 | — | ||
| Q3 25 | $7.11 | — | ||
| Q2 25 | $4.34 | — | ||
| Q1 25 | $-0.57 | — | ||
| Q4 24 | $2.57 | — | ||
| Q3 24 | $5.20 | — | ||
| Q2 24 | $1.98 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.2B | $1.7B |
| Total DebtLower is stronger | $816.0M | — |
| Stockholders' EquityBook value | $15.7B | $15.4B |
| Total Assets | $41.2B | $33.5B |
| Debt / EquityLower = less leverage | 0.05× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.2B | — | ||
| Q4 25 | $148.0M | $1.7B | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.3B | $1.3B | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $771.0M | — |
| Q1 26 | $816.0M | — | ||
| Q4 25 | $861.0M | — | ||
| Q3 25 | $858.0M | — | ||
| Q2 25 | $859.0M | — | ||
| Q1 25 | $853.0M | — | ||
| Q4 24 | $850.0M | — | ||
| Q3 24 | $849.0M | — | ||
| Q2 24 | $849.0M | — |
| Q1 26 | $15.7B | — | ||
| Q4 25 | $15.9B | $15.4B | ||
| Q3 25 | $15.4B | — | ||
| Q2 25 | $14.3B | — | ||
| Q1 25 | $13.7B | — | ||
| Q4 24 | $13.9B | $17.0B | ||
| Q3 24 | $13.8B | — | ||
| Q2 24 | $12.8B | — |
| Q1 26 | $41.2B | — | ||
| Q4 25 | $41.0B | $33.5B | ||
| Q3 25 | $40.6B | — | ||
| Q2 25 | $38.8B | — | ||
| Q1 25 | $37.3B | — | ||
| Q4 24 | $36.5B | $36.3B | ||
| Q3 24 | $37.0B | — | ||
| Q2 24 | $34.8B | — |
| Q1 26 | 0.05× | — | ||
| Q4 25 | 0.05× | — | ||
| Q3 25 | 0.06× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.06× | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.9B |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 6.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $947.0M | $2.9B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $741.0M | — | ||
| Q1 25 | $310.0M | — | ||
| Q4 24 | $642.0M | $2.6B | ||
| Q3 24 | $912.0M | — | ||
| Q2 24 | $742.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $939.0M | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $737.0M | — | ||
| Q1 25 | $307.0M | — | ||
| Q4 24 | $638.0M | — | ||
| Q3 24 | $906.0M | — | ||
| Q2 24 | $737.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 30.4% | — | ||
| Q3 25 | 29.8% | — | ||
| Q2 25 | 22.7% | — | ||
| Q1 25 | 12.0% | — | ||
| Q4 24 | 25.1% | — | ||
| Q3 24 | 27.3% | — | ||
| Q2 24 | 29.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.40× | 6.67× | ||
| Q3 25 | 0.99× | — | ||
| Q2 25 | 1.08× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.59× | 20.20× | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 2.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
